Amy Patterson

Dr. Patterson is the Deputy Director for Clinical Research and Strategic Initiatives in the Immediate Office of the Director (IOD) of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).  In this role, she provides leadership and strategic coordination of trans-NHLBI efforts and manages a broad portfolio of issues germane to the conduct of clinical research, research oversight, policy development, major new scientific initiatives, and relationships with organizations within and external to the Institute. 

Prior to joining the NHLBI in 2015, Dr. Patterson served as the NIH Associate Director for Science Policy and as the NIH Associate Director for Biosecurity and Biosafety Policy. Her responsibilities encompassed areas such as human subjects protections; the organization and oversight of clinical trials; scientific, social, and ethical considerations in genetics research and human gene transfer trials; and safety and security implications of emerging new technologies.

Prior to coming to the NIH Office of the Director, she served as the Deputy Director of the Division of Cellular and Gene Therapies and Medical Officer in the Division of Clinical Trial Design and Analysis at the FDA Center for Biologics Evaluation and Research.  Dr. Patterson received her B.A. (Cum Laude) in biology from Harvard University and her M.D. (Alpha Omega Alpha) from Albert Einstein College of Medicine.  She conducted her internship and residency in internal medicine at New York Hospital and Memorial Sloan Kettering and completed her post-doctoral clinical research fellowships in adult and pediatric endocrinology and metabolism at the NIH.